HLA-A.md
... ...
@@ -28,14 +28,14 @@ timeline
28 28
29 29
|pathology |Samples |Incidence estimate |
30 30
|:---------|:-------------------|:----------------------|
31
- |DLBCL |GAMBL without Reddy[@reddyGeneticFunctionalDrivers2017] |0.0985 [0.0808,0.1163] |
32
- |DLBCL |GAMBL with Reddy[@reddyGeneticFunctionalDrivers2017] |0.0112 [0.0062,0.0162] |
31
+ |DLBCL |GAMBL without Reddy |0.0985 [0.0808,0.1163] |
32
+ |DLBCL |GAMBL with Reddy |0.0112 [0.0062,0.0162] |
33 33
|DLBCL |BC |0.0987 [0.0595,0.1378] |
34
- |DLBCL |Dana-Farber |0.0924 [0.0598,0.125] |
35
- |DLBCL |NCI |0.1106 [0.0823,0.139] |
34
+ |DLBCL |Dana-Farber[@chapuyMolecularSubtypesDiffuse2018] |0.0924 [0.0598,0.125] |
35
+ |DLBCL |NCI[@schmitzGeneticsPathogenesisDiffuse2018] |0.1106 [0.0823,0.139] |
36 36
|DLBCL |Reddy[@reddyGeneticFunctionalDrivers2017] |0.0037 [0,0.0089] |
37 37
|DLBCL |DLBCL_ICGC |0.0706 [0.0161,0.125] |
38
-
38
+
39 39
## Mutation pattern and selective pressure estimates
40 40
41 41
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|